Abstract
A placebo response refers to the improvement in a patient's clinical symptoms when administered with an inert substance, whereas a nocebo response is the worsening of clinical symptoms. The neuropeptide oxytocin is implicated in social trust, stress/anxiety, and learning processes that also contribute to placebo and nocebo responses. This leads to an intriguing hypothesis that pharmacological manipulation of oxytocin 1nay modulate placebo/nocebo. It has been proposed that oxytocin may enhance social trust, a key element of the patient-doctor relationship, which may further boost placebo effects. Oxytocin has also been shown to be involved in reducing stress and anxiety, which might contribute significantly to the magnitude of nocebo.
| Original language | English |
|---|---|
| Pages (from-to) | 185-187 |
| Number of pages | 3 |
| Journal | Psychotherapy and Psychosomatics |
| Volume | 89 |
| Issue number | 3 |
| Early online date | 20 Dec 2019 |
| DOIs | |
| Publication status | Published - May 2020 |
| Externally published | Yes |
Funding
This work was supported by the Natural Scientific Foundation of China (No. 81771186).
Keywords
- Adolescent
- Adult
- Female
- Humans
- Hyperalgesia/drug therapy
- Male
- Nocebo Effect
- Oxytocin/therapeutic use
- Pain Management
- Placebo Effect
- Young Adult